Hjem › Blærecancer › Michigan › Lansing
Blærecancer kliniske forsøg i Lansing, MI
5 studier for Blærecancer søger deltagere på steder i og omkring Lansing (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- University of Michigan Health - Sparrow Lansing, Lansing
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
RekruttererFase 2
- University of Michigan Health - Sparrow Lansing, Lansing
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruttererFase 2
- University of Michigan Health - Sparrow Lansing, Lansing
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RekruttererFase 2
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservationsstudie
- Massive Bio SYNERGY-AI site, Lansing
Blærecancer forsøg i andre byer
- New York City, NY35 studier
- Nashville, TN31 studier
- Houston, TX31 studier
- Dallas, TX27 studier
- Boston, MA26 studier
- Washington, DC26 studier
- Los Angeles, CA24 studier
- Baltimore, MD24 studier
- St. Louis, MO22 studier
- Philadelphia, PA21 studier
- Seattle, WA21 studier
- Edison, NJ21 studier
Andre studier i Lansing
- Lungecancer11 studier
- Prostatakræft10 studier
- Brystkræft10 studier
- Ikke-småcellet lungecancer9 studier
- Kræft (alle typer)6 studier
- Larynxcancer5 studier
- Forstyrrelser med overdreven søvnighed5 studier
- Colorektal kræft4 studier
- Nyrekancer (renocellulært karcinom)4 studier
- Tyktarmskræft4 studier
- Urotelial (overgangscelle) carcinom4 studier
- Pladecellekræft i hoved og hals4 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.